SOLV Solventum Corp: Company Value to Revenue Ratio

Solventum Corp (SOLV) - corporate logo

Global sales for Solventum Corporation (SOLV) are constrained by disruptions in Asian electronics supplies, while sanctions and military conflicts exacerbate the shortage of chemical raw materials for medical technology. The business value-to-revenue trend captures these complexities, with 2374.94 recorded as the baseline value. Looking ahead, modest price growth driven by hospital budget austerity may limit the expansion of this dental segment leader.

SOLV (Solventum Inc.) Company Value to Revenue history from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for Solventum Inc. (SOLV)

- price and consensus price forecast:
Fundamental company valuation:Solventum Corporation
Manufactured product of Solventum Corp

For Solventum Corporation (SOLV), the EV/Sales multiple determines the value of the entire business, including debt, relative to the revenue generated. The dynamics of the EV/Sales multiple allow an investor to strip away the impact of the debt load and assess the real market value of one dollar of revenue. The integration of AI into medical automation increases clinic efficiency, which, given the moderate levels on the chart, confirms the fundamental stability and fair valuation of the company.

Competitor analysis

Enterprise Value-to-Revenue Multiple hcahealthcare.com|THC: EV/Sales Multiple|FMS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Encompass|EV/Sales Multiple uhsinc.com|Enterprise Value-to-Revenue Ratio DaVita (DVA)|Total Company Value-to-Revenue Ratio radnet.com|EV/Sales Multiple OPCH (optioncarehealth.com)|SGRY (Surgery Partners) - Enterprise Value to Sales Volume|PINC - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio America's Best Contacts & Eyeglasses EYE|PGNY: EV/Sales Multiple|ARDT (Ardent Health Partners) - Enterprise Value-to-Revenue Ratio|SEM (selectmedical.com) - EV/Sales Multiple|Enterprise Value-to-Revenue Ratio ASTH|EV/Sales Multiple MD|Enterprise Value-to-Revenue Ratio USPH (US Physical Therapy Inc)|Enterprise Value-to-Revenue Ratio The Pennant Group, Inc. PNTG|Business Value to Revenue ORGO|NUTX - Enterprise Value-to-Revenue Ratio|AUNA - EV/Sales Multiple|SBC Medical Group Inc (SBC) - Enterprise Value-to-Revenue Ratio|EOLS: Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio chs.net|SKIN: Business Value to Revenue|EV/Sales Multiple MDWD|BTMD - Enterprise Value-to-Revenue Multiple|The Joint Chiropractic - Company Value to Revenue|Enterprise Value-to-Revenue Coefficient DCGO (DocGo, Inc)|Total Company Value-to-Revenue Ratio PIII (p3hp.org)|GANX (Gain Therapeutics) - Company Value to Revenue Ratio|euda.com (EUDA) - Enterprise Value-to-Revenue Ratio|Company Value to Revenue Basel Medical|CLGN (CollPlant Biotechnologies) - EV/Sales Multiple|EV/Sales Multiple Cuprina Holdings Limited|Enterprise Value-to-Revenue Ratio concordmedical.com (CCM)|Enterprise Value-to-Revenue Ratio AMS (American Shared Hospital)|Enterprise Value-to-Revenue Ratio MEDIROM Corp MRM|EV/Sales Multiple avalon-globocare.com ALBT|DHAI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Company Value to Revenue|ATI Physical Therapy Inc. - Business Value to Revenue|CMAX (caremax.com) - EV/Sales Multiple|KDLY (Kindly MD Inc) - Enterprise Value-to-Revenue Coefficient|Enterprise Value-to-Revenue Ratio ModivCare Corp (MODV)|Total Company Value-to-Revenue Ratio Novo Integrated Sciences|SunLink Health Systems, Inc. - Company Value to Revenue|imacholdings.comm (BACK) - Enterprise Value-to-Revenue Multiple